City

Boston (1)

Candiolo (1)

Houston (1)

Overall Status

Recruiting (2)

Completed (1)

Phase

phase 1 (2)

phase 2 (1)

Sponsor

Baylor College of Medicine (1)

Dana-Farber Cancer Institute (1)

Italian Sarcoma Group (1)

Collaborator

Cancer Prevention Research Institute of Texas (1)

Center for Cell and Gene Therapy, Baylor College of Medicine (1)

The Methodist Hospital Research Institute (1)

Intervention

cyclophosphamide (2)

c7r-gd2.cart cells (1)

cabozantinib (1)

everolimus (1)

fludarabine (1)

myeloid growth factor (1)

sorafenib (1)

topotecan (1)

Study Documents

Intervention Type

drug (3)

genetic (1)

Funder Type

Other (3)

Study Type

Interventional (3)

relapsed osteosarcoma

Showing 1 - 3 of 3

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Relapsed Neuroblastoma, Refractory Neuroblastoma, Relapsed Osteosarcoma Trial in Houston (C7R-GD2.CART cells, Cyclophosphamide,

Recruiting

Relapsed Neuroblastoma
+6 more

C7R-GD2.CART cells
+2 more

Houston, Texas
+1 more

Nov 12, 2021

Relapsed Ewing Sarcoma, Refractory Ewing Sarcoma, Relapsed Osteosarcoma Trial in Boston (Cabozantinib, Topotecan,

Recruiting

Relapsed Ewing Sarcoma
+3 more

Cabozantinib
+3 more

Boston, Massachusetts
+1 more

Sep 27, 2021

Metastatic Osteosarcoma, Relapsed Osteosarcoma Trial in Candiolo (Sorafenib, Everolimus)

Completed

Metastatic Osteosarcoma
Relapsed Osteosarcoma

Candiolo, Torino, Italy

Fondazione del Piemonte per l'Oncologia IRCC Candiolo

Jun 16, 2015